Therapeutic approach to epileptic encephalopathies
Abstract
Epileptic encephalopathies (EEs) are electroclinical entities with a peculiar course of disease; seizures and electroencephalographic (EEG) epileptiform abnormalities, ictal and interictal, contribute to progressive disturbance of cerebral functions. Frequently EEs are drug resistant, and consequences may be catastrophic. The main goal of treatment is to stop the peculiar course of epilepsy, operating on three parameters: seizure control, reduction of EEG abnormalities, and developmental outcome. For a correct therapeutic approach it is mandatory to have an as accurate as possible syndromic and etiologic diagnosis. Given the poor efficacy of conventional antiepileptic drugs (AEDs), the use of specific drugs for EEs, such as adrenocorticotropic hormone (ACTH) and corticosteroids or stiripentol is suggested. In some cases the choice of treatment is strictly related to the etiology: vigabatrin in tuberous sclerosis, ketogenic diet in glucose transporter type 1 (GLUT-1) deficiency, and pyridoxine in pyridoxine deficiency. Some AEDs combinations, such as sodium valproate with lamotrigine, have also provided interesting results, for example, in Lennox-Gastaut syndrome, although controlled studies are lacking. Finally, early surgery can be an option in children with focal structural abnormalities responsible for EEs preferably before irreversible damage on developmental outcome. Multispecialist support is recommended in EE. Management should be global from the onset, integrating not only seizure control but also all issues related to comorbidities, particularly neuropsychological and psychiatric.Keywords
This publication has 31 references indexed in Scilit:
- Myoclonic astatic epilepsy (Doose syndrome) – A lamotrigine responsive epilepsy?European Journal of Paediatric Neurology, 2013
- Nonpharmacologic treatments of Dravet syndrome: Focus on the ketogenic dietEpilepsia, 2011
- The pharmacologic treatment of Dravet syndromeEpilepsia, 2011
- Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trialArchives of Disease in Childhood, 2010
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia, 2010
- Corticosteroids as treatment of epileptic syndromes with continuous spike‐waves during slow‐wave sleepEpilepsia, 2009
- Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodologyThe Lancet Neurology, 2009
- A Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy: Report of the ILAE Task Force on Classification and TerminologyEpilepsia, 2001
- Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trialThe Lancet, 2000
- Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosisEpilepsy Research, 1997